Clinical lymphoma, myeloma & leukemia
Improved Outcomes Following the Adoption of Targeted Therapies in High-Risk Chronic Lymphocytic Leukemia Treated in Southern Finland.
Tuija Tapaninen, Vesa Lindström, Olivia Hölsä, Emma-Leena Alarmo, Liisa Ukkola-Vuoti, Kimmo Porkka, Oscar Brück
Published: 202510.1016/j.clml.2025.12.002
Abstract
BACKGROUND: Targeted therapies have replaced chemoimmunotherapy for chronic lymphocytic leukemia (CLL), but high-risk CLL patients with TP53 aberrations continue to represent a significant unmet medical need. We profiled treatment patterns, outcomes,…
Preview only. Read the full abstract at the source